Portfolio Holdings Detail for ISIN IE00BMBKBZ46
Stock Name / Fund iShares S&P 500 Health Care Sector UCITS ETF
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IUHE.AS(EUR) CXE
ETF Ticker IUHE(EUR) Euronext Amsterdam

Holdings detail for CRL

Stock Name	Creightons Plc
Ticker	CRL(GBX) LSE
TYPE	Common Stock
Country	UK
ISIN	GB0002341666
LEI	213800WROWAJUBGSAJ57

Show aggregate CRL holdings

News associated with CRL

Charles River Laboratories International (NYSE:CRL) Downgraded to “Buy” Rating by Wall Street Zen: Wall Street Zen lowered shares of Charles River Laboratories International (NYSE:CRL – Free Report) from a strong-buy rating to a buy rating in a report issued on Sunday morning. Several other research firms also recently issued reports on CRL. Evercore ISI lifted their price target on Charles River Laboratories International from $180.00 to $190.00 and […] - 2025-09-22 03:13:04
Charles River CFO Flavia Pease To Step Down; Michael Knell Appointed Interim CFO: (RTTNews) - Charles River Laboratories International, Inc. (CRL) announced Tuesday that Flavia H. Pease, corporate executive vice president and chief financial officer, has resigned effective September 29, 2025, to pursue another opportunity. - 2025-09-16 08:28:15
Brokerages Set Charles River Laboratories International, Inc. (NYSE:CRL) PT at $175.69: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received a consensus rating of “Hold” from the fifteen research firms that are covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and five have given a buy recommendation to […] - 2025-08-29 04:49:03
Wall Street Zen Downgrades Charles River Laboratories International (NYSE:CRL) to Buy: Charles River Laboratories International (NYSE:CRL – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Sunday. CRL has been the topic of a number of other reports. Robert W. Baird upped their price objective on Charles […] - 2025-08-19 02:50:57
Maryland State Retirement & Pension System Reduces Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Maryland State Retirement & Pension System lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,387 shares of the medical research company’s stock after […] - 2025-08-17 05:17:00
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.4% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 577,322 shares of the medical research company’s stock after purchasing an additional 24,347 […] - 2025-08-13 05:42:56
Federated Hermes Inc. Lowers Position in Charles River Laboratories International, Inc. (NYSE:CRL): Federated Hermes Inc. cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 90.6% in the first quarter, Holdings Channel reports. The fund owned 225 shares of the medical research company’s stock after selling 2,172 shares during the quarter. Federated Hermes Inc.’s holdings in Charles River Laboratories International were worth $34,000 […] - 2025-08-12 05:06:53
Analysts Expect 10% Gains Ahead For The Holdings of SPUS: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-11 10:38:26
Kestra Private Wealth Services LLC Sells 115 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Kestra Private Wealth Services LLC lowered its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 5.6% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,929 shares of the medical research company’s stock after selling 115 […] - 2025-07-28 05:24:49
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Mutual of America Capital Management LLC: Mutual of America Capital Management LLC trimmed its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.9% in the first quarter, HoldingsChannel reports. The institutional investor owned 5,938 shares of the medical research company’s stock after selling 179 shares during the period. Mutual of America Capital Management LLC’s holdings […] - 2025-07-22 07:06:50
Arizona State Retirement System Sells 336 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Arizona State Retirement System decreased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 2.2% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,659 shares of the medical research company’s stock after selling 336 shares during the quarter. Arizona […] - 2025-07-18 05:10:58
Nisa Investment Advisors LLC Decreases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Nisa Investment Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,737 shares of the medical research company’s stock after selling 1,417 shares during […] - 2025-07-16 05:44:56
Brown Advisory Inc. Has $334,000 Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Brown Advisory Inc. lowered its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 84.9% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,219 shares of the medical research company’s stock after selling 12,506 shares during the period. Brown Advisory […] - 2025-07-16 04:56:59
Teacher Retirement System of Texas Takes $1.23 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL): Teacher Retirement System of Texas acquired a new stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) in the 1st quarter, Holdings Channel.com reports. The institutional investor acquired 8,180 shares of the medical research company’s stock, valued at approximately $1,231,000. Several other hedge funds also recently modified their holdings of the stock. Aaron […] - 2025-07-13 06:14:56
Charles River Laboratories International Reaches Analyst Target Price: In recent trading, shares of Charles River Laboratories International Inc. (Symbol: CRL) have crossed above the average analyst 12-month target price of $158.64, changing hands for $158.97/share. When a stock reaches the target an analyst has set, the analyst logically has two w - 2025-07-10 07:56:40
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of “Hold” by Analysts: Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) has received an average rating of “Hold” from the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and four have assigned a buy recommendation to the company. […] - 2025-07-07 04:26:46
New York State Teachers Retirement System Sells 4,446 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): New York State Teachers Retirement System lessened its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 9.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,784 shares of the medical research company’s stock after selling 4,446 shares […] - 2025-07-06 07:56:57
Sequoia Financial Advisors LLC Has $264,000 Position in Charles River Laboratories International, Inc. (NYSE:CRL): Sequoia Financial Advisors LLC reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 10.6% in the first quarter, HoldingsChannel.com reports. The fund owned 1,755 shares of the medical research company’s stock after selling 207 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Charles River Laboratories International […] - 2025-07-04 04:45:03
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC trimmed its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,723 shares of the medical research company’s stock after selling 247 shares during the period. […] - 2025-07-03 04:26:50
Bessemer Group Inc. Sells 16,538 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Bessemer Group Inc. trimmed its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 70.5% during the first quarter, HoldingsChannel.com reports. The fund owned 6,935 shares of the medical research company’s stock after selling 16,538 shares during the quarter. Bessemer Group Inc.’s holdings in Charles River Laboratories International were worth $1,044,000 at […] - 2025-07-01 05:46:49
Asset Management One Co. Ltd. Sells 17,428 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Asset Management One Co. Ltd. lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 92.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,490 shares of the medical research company’s stock after selling 17,428 shares during the […] - 2025-07-01 04:54:50
Congress Trade: Representative Jefferson Shreve Just Disclosed New Stock Trades: Representative Jefferson Shreve just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Jefferson Shreve and other politicians. - 2025-06-23 10:13:39
Charles River Laboratories International, Inc. (NYSE:CRL) Shares Purchased by Blue Trust Inc.: Blue Trust Inc. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 60.1% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,407 shares of the medical research company’s stock after acquiring an additional 904 shares during the period. Blue Trust Inc.’s holdings in Charles River Laboratories International […] - 2025-06-23 06:18:50
Yousif Capital Management LLC Has $856,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL): Yousif Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.6% in the first quarter, Holdings Channel.com reports. The firm owned 5,687 shares of the medical research company’s stock after selling 215 shares during the period. Yousif Capital Management LLC’s holdings in Charles River Laboratories […] - 2025-06-20 04:32:47
Tuesday Sector Laggards: Healthcare, Technology & Communications: The worst performing sector as of midday Tuesday is the Healthcare sector, showing a 1.4% loss. Within the sector, Charles River Laboratories International Inc. (Symbol: CRL) and Align Technology Inc (Symbol: ALGN) are two large stocks that are lagging, showing a loss of 4.4% an - 2025-06-17 15:32:11
Fifth Third Bancorp Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL): Fifth Third Bancorp lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 8,747 shares of the medical research company’s stock after selling 2,030 shares during the […] - 2025-06-16 05:32:50
Handelsbanken Fonder AB Has $1.74 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Handelsbanken Fonder AB reduced its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,537 shares of the medical research company’s stock after selling 900 shares during the […] - 2025-06-15 06:40:51
Congress Asset Management Co. Sells 1,482 Shares of Charles River Laboratories International, Inc. (NYSE:CRL): Congress Asset Management Co. lessened its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 34.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,879 shares of the medical research company’s stock after selling 1,482 shares during […] - 2025-06-10 05:04:52
Rhumbline Advisers Has $13.06 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL): Rhumbline Advisers boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 4.1% in the first quarter, HoldingsChannel reports. The firm owned 86,730 shares of the medical research company’s stock after acquiring an additional 3,405 shares during the period. Rhumbline Advisers’ holdings in Charles River Laboratories International were worth […] - 2025-06-09 06:02:56
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.58 Million in Charles River Laboratories International, Inc. (NYSE:CRL): Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 19,410 shares of the medical research company’s stock, valued at approximately $3,583,000. A number of other […] - 2025-06-02 05:58:52

iShares S&P 500 Health Care Sector UCITS ETF CRL holdings

Date	Number of CRL Shares Held	Base Market Value of CRL Shares	Local Market Value of CRL Shares	Change in CRL Shares Held	Change in CRL Base Value	Current Price per CRL Share Held	Previous Price per CRL Share Held
2025-12-04 (Thursday)	24,274	USD 4,467,387	USD 4,467,387
2025-12-03 (Wednesday)	24,274	USD 4,482,680	USD 4,482,680	0	USD 240,556	USD 184.67	USD 174.76
2025-12-02 (Tuesday)	24,274	USD 4,242,124	USD 4,242,124	-297	USD -84,583	USD 174.76	USD 176.09
2025-12-01 (Monday)	24,571	USD 4,326,707	USD 4,326,707	9	USD -48,768	USD 176.09	USD 178.14
2025-11-28 (Friday)	24,562	USD 4,375,475	USD 4,375,475	162	USD 9,339	USD 178.14	USD 178.94
2025-11-27 (Thursday)	24,400	USD 4,366,136	USD 4,366,136	0	USD 0	USD 178.94	USD 178.94
2025-11-26 (Wednesday)	24,400	USD 4,366,136	USD 4,366,136	-54	USD 12,101	USD 178.94	USD 178.05
2025-11-25 (Tuesday)	24,454	USD 4,354,035	USD 4,354,035	54	USD 195,299	USD 178.05	USD 170.44
2025-11-24 (Monday)	24,400	USD 4,158,736	USD 4,158,736	135	USD 90,951	USD 170.44	USD 167.64
2025-11-21 (Friday)	24,265	USD 4,067,785	USD 4,067,785	0	USD 134,914	USD 167.64	USD 162.08
2025-11-20 (Thursday)	24,265	USD 3,932,871	USD 3,932,871	27	USD 15,041	USD 162.08	USD 161.64
2025-11-19 (Wednesday)	24,238	USD 3,917,830	USD 3,917,830	0	USD -21,572	USD 161.64	USD 162.53
2025-11-18 (Tuesday)	24,238	USD 3,939,402	USD 3,939,402	0	USD -5,090	USD 162.53	USD 162.74
2025-11-17 (Monday)	24,238	USD 3,944,492	USD 3,944,492	0	USD -122,887	USD 162.74	USD 167.81

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRL by Blackrock for IE00BMBKBZ46

Show aggregate share trades of CRL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 SELL -297 177.010 172.950 173.356 GBX -51,487 160.95 Loss of -3,686 on sale
2025-12-01 BUY 9 180.950 175.710 176.234 GBX 1,586 160.88
2025-11-28 BUY 162 178.530 176.930 177.090 GBX 28,689 160.80
2025-11-26 SELL -54 179.190 176.665 176.917 GBX -9,554 160.64 Loss of -879 on sale
2025-11-26 SELL -54 179.190 176.665 176.917 GBX -9,554 160.64 Loss of -879 on sale
2025-11-25 BUY 54 178.540 170.780 171.556 GBX 9,264 160.56
2025-11-24 BUY 135 171.720 167.450 167.877 GBX 22,663 160.51
2025-11-20 BUY 27 165.480 160.805 161.272 GBX 4,354 160.47
2025-11-12 SELL -108 174.450 171.060 171.399 GBX -18,511 160.31 Loss of -1,197 on sale
2025-11-10 BUY 270 172.830 166.960 167.547 GBX 45,238 160.21
2025-11-06 BUY 27 175.000 165.740 166.666 GBX 4,500 160.12
2025-11-05 SELL -27 170.140 160.010 161.023 GBX -4,348 160.08 Loss of -25 on sale
2025-11-04 BUY 27 180.185 175.827 176.262 GBX 4,759 160.00
2025-10-31 BUY 135 181.560 178.170 178.509 GBX 24,099 159.80
2025-10-30 SELL -162 182.040 177.490 177.945 GBX -28,827 159.71 Loss of -2,955 on sale
2025-10-29 SELL -54 180.150 191.410 190.284 GBX -10,275 159.60 Loss of -1,657 on sale
2025-10-28 BUY 52 187.930 193.470 192.916 GBX 10,032 159.46
2025-10-27 SELL -54 195.280 198.000 197.728 GBX -10,677 159.28 Loss of -2,076 on sale
2025-10-22 SELL -27 187.000 190.690 190.321 GBX -5,139 158.78 Loss of -852 on sale
2025-10-17 SELL -108 178.520 178.770 178.745 GBX -19,304 158.40 Loss of -2,198 on sale
2025-10-16 BUY 135 174.950 177.750 177.470 GBX 23,958 158.31
2025-10-15 BUY 189 170.720 173.020 172.790 GBX 32,657 158.24
2025-10-14 BUY 27 170.130 172.410 172.182 GBX 4,649 158.18
2025-10-03 BUY 54 177.330 181.450 181.038 GBX 9,776 158.08
2025-10-02 BUY 27 175.360 178.190 177.907 GBX 4,803 157.99
2025-10-01 BUY 158 170.480 170.660 170.642 GBX 26,961 157.92
2025-09-18 BUY 27 156.990 157.630 157.566 GBX 4,254 158.16
2025-09-11 BUY 27 159.740 159.780 159.776 GBX 4,314 158.22
2025-09-10 BUY 27 153.270 157.970 157.500 GBX 4,253 158.25
2025-08-20 BUY 54 159.580 159.620 159.616 GBX 8,619 158.27
2025-08-19 BUY 27 158.480 160.000 159.848 GBX 4,316 158.26
2025-08-18 BUY 135 156.980 158.190 158.069 GBX 21,339 158.27
2025-08-15 BUY 402 156.680 158.160 158.012 GBX 63,521 158.28
2025-08-14 BUY 162 155.800 155.930 155.917 GBX 25,259 158.30
2025-08-13 BUY 108 155.000 155.430 155.387 GBX 16,782 158.32
2025-07-30 BUY 27 176.190 180.020 179.637 GBX 4,850 158.24
2025-07-17 SELL -27 156.700 156.950 156.925 GBX -4,237 157.74 Profit of 22 on sale
2025-07-15 SELL -108 154.420 159.490 158.983 GBX -17,170 157.77 Loss of -131 on sale
2025-07-14 SELL -270 158.040 160.410 160.173 GBX -43,247 157.77 Loss of -648 on sale
2025-07-09 SELL -27 158.970 163.590 163.128 GBX -4,404 157.72 Loss of -146 on sale
2025-07-07 SELL -54 153.900 156.720 156.438 GBX -8,448 157.74 Profit of 70 on sale
2025-07-02 BUY 27 157.490 158.380 158.291 GBX 4,274 157.75
2025-06-24 SELL -459 148.400 149.680 149.552 GBX -68,644 158.01 Profit of 3,881 on sale
2025-06-23 BUY 27 147.380 148.320 148.226 GBX 4,002 158.08
2025-06-20 SELL -1,403 147.450 147.740 147.711 GBX -207,239 158.16 Profit of 14,659 on sale
2025-06-18 SELL -28 145.290 147.100 146.919 GBX -4,114 158.35 Profit of 320 on sale
2025-06-17 BUY 336 145.050 150.540 149.991 GBX 50,397 158.45
2025-06-13 SELL -56 149.450 152.640 152.321 GBX -8,530 158.57 Profit of 350 on sale
2025-06-11 SELL -28 151.110 154.430 154.098 GBX -4,315 158.67 Profit of 128 on sale
2025-06-10 SELL -56 151.000 152.430 152.287 GBX -8,528 158.73 Profit of 361 on sale
2025-06-09 SELL -84 147.460 149.030 148.873 GBX -12,505 158.82 Profit of 836 on sale
2025-05-21 SELL -28 134.980 141.710 141.037 GBX -3,949 161.13 Profit of 562 on sale
2025-05-20 SELL -56 143.530 143.820 143.791 GBX -8,052 161.28 Profit of 979 on sale
2025-05-15 SELL -84 138.890 139.380 139.331 GBX -11,704 161.83 Profit of 1,890 on sale
2025-05-14 SELL -84 138.950 146.430 145.682 GBX -12,237 162.04 Profit of 1,374 on sale
2025-05-13 BUY 28 144.020 145.640 145.478 GBX 4,073 162.20
2025-05-09 SELL -28 138.790 143.460 142.993 GBX -4,004 162.59 Profit of 549 on sale
2025-05-08 BUY 56 141.360 143.860 143.610 GBX 8,042 162.78
2025-05-01 BUY 56 116.890 120.140 119.815 GBX 6,710 164.79
2025-04-24 SELL -28 115.760 115.940 115.922 GBX -3,246 167.27 Profit of 1,438 on sale
2025-04-23 BUY 84 109.000 116.060 115.354 GBX 9,690 167.87
2025-04-15 SELL -28 105.920 107.580 107.414 GBX -3,008 171.99 Profit of 1,808 on sale
2025-04-11 SELL -56 99.750 101.360 101.199 GBX -5,667 173.54 Profit of 4,051 on sale
2025-04-08 SELL -28 123.610 137.960 136.525 GBX -3,823 175.38 Profit of 1,088 on sale
2025-04-07 SELL -28 134.070 139.160 138.651 GBX -3,882 175.86 Profit of 1,042 on sale
2025-04-04 SELL -56 136.900 140.150 139.825 GBX -7,830 176.33 Profit of 2,044 on sale
2025-04-02 BUY 28 149.280 150.160 150.072 GBX 4,202 176.65
2025-04-01 BUY 252 145.990 151.370 150.832 GBX 38,010 177.03
2025-03-31 SELL -168 150.520 153.820 153.490 GBX -25,786 177.35 Profit of 4,009 on sale
2025-03-28 BUY 28 155.550 158.710 158.394 GBX 4,435 177.63
2025-03-26 SELL -19 158.250 162.320 161.913 GBX -3,076 178.12 Profit of 308 on sale
2025-03-21 BUY 196 167.280 167.940 167.874 GBX 32,903 178.64
2025-03-20 BUY 112 165.350 171.710 171.074 GBX 19,160 178.82
2025-03-17 SELL -28 175.010 175.600 175.541 GBX -4,915 178.97 Profit of 96 on sale
2025-03-12 BUY 1,035 170.590 171.190 171.130 GBX 177,120 179.39
2025-03-07 BUY 27 175.920 177.240 177.108 GBX 4,782 179.70
2025-02-28 SELL -81 165.310 165.820 165.769 GBX -13,427 180.66 Profit of 1,206 on sale
2025-02-25 BUY 270 167.100 172.430 171.897 GBX 46,412 181.38
2025-02-20 BUY 189 162.250 168.020 167.443 GBX 31,647 182.26
2025-02-19 BUY 81 165.000 166.440 166.296 GBX 13,470 182.58
2025-02-18 BUY 54 154.390 155.690 155.560 GBX 8,400 183.11
2025-02-13 BUY 135 153.170 155.290 155.078 GBX 20,936 184.96
2025-02-04 BUY 108 163.120 169.670 169.015 GBX 18,254 188.84
2025-01-31 BUY 27 164.760 167.090 166.857 GBX 4,505 190.09
2025-01-29 BUY 27 161.640 163.000 162.864 GBX 4,397 191.44
2025-01-27 BUY 54 165.840 168.550 168.279 GBX 9,087 192.89
2025-01-24 BUY 27 164.970 168.150 167.832 GBX 4,531 193.66
2025-01-02 SELL -972 182.640 187.320 186.852 GBX -181,620 194.78 Profit of 7,702 on sale
2024-12-10 SELL -27 197.050 202.720 202.153 GBX -5,458 194.71 Loss of -201 on sale
2024-12-09 SELL -702 201.750 202.570 202.488 GBX -142,147 194.49 Loss of -5,617 on sale
2024-12-03 SELL -324 199.300 201.120 200.938 GBX -65,104 194.34 Loss of -2,137 on sale
2024-12-02 SELL -135 201.250 203.010 202.834 GBX -27,383 194.09 Loss of -1,181 on sale
2024-11-29 SELL -27 199.060 201.290 201.067 GBX -5,429 193.89 Loss of -194 on sale
2024-11-22 SELL -270 195.770 198.180 197.939 GBX -53,444 192.73 Loss of -1,407 on sale
2024-11-21 SELL -135 194.190 194.880 194.811 GBX -26,299 192.65 Loss of -291 on sale
2024-11-20 BUY 216 187.900 188.320 188.278 GBX 40,668 192.90
2024-11-18 SELL -324 187.500 187.930 187.887 GBX -60,875 193.62 Profit of 1,858 on sale
2024-11-11 BUY 243 220.690 222.100 221.959 GBX 53,936 190.33
2024-11-08 SELL -864 215.390 216.150 216.074 GBX -186,688 188.54 Loss of -23,789 on sale
2024-11-07 SELL -54 210.290 217.600 216.869 GBX -11,711 186.87 Loss of -1,620 on sale
2024-11-01 SELL -54 180.960 184.040 183.732 GBX -9,922 184.77 Profit of 56 on sale
2024-10-31 SELL -108 178.580 181.230 180.965 GBX -19,544 185.55 Profit of 495 on sale
2024-10-30 BUY 27 181.390 186.370 185.872 GBX 5,019 186.14
2024-10-29 BUY 162 184.000 186.460 186.214 GBX 30,167 186.50
2024-10-28 SELL -81 186.520 188.000 187.852 GBX -15,216 186.49 Loss of -110 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	SELL	-297	177.010	172.950	173.356	GBX -51,487	160.95 Loss of -3,686 on sale
2025-12-01	BUY	9	180.950	175.710	176.234	GBX 1,586	160.88
2025-11-28	BUY	162	178.530	176.930	177.090	GBX 28,689	160.80
2025-11-26	SELL	-54	179.190	176.665	176.917	GBX -9,554	160.64 Loss of -879 on sale
2025-11-26	SELL	-54	179.190	176.665	176.917	GBX -9,554	160.64 Loss of -879 on sale
2025-11-25	BUY	54	178.540	170.780	171.556	GBX 9,264	160.56
2025-11-24	BUY	135	171.720	167.450	167.877	GBX 22,663	160.51
2025-11-20	BUY	27	165.480	160.805	161.272	GBX 4,354	160.47
2025-11-12	SELL	-108	174.450	171.060	171.399	GBX -18,511	160.31 Loss of -1,197 on sale
2025-11-10	BUY	270	172.830	166.960	167.547	GBX 45,238	160.21
2025-11-06	BUY	27	175.000	165.740	166.666	GBX 4,500	160.12
2025-11-05	SELL	-27	170.140	160.010	161.023	GBX -4,348	160.08 Loss of -25 on sale
2025-11-04	BUY	27	180.185	175.827	176.262	GBX 4,759	160.00
2025-10-31	BUY	135	181.560	178.170	178.509	GBX 24,099	159.80
2025-10-30	SELL	-162	182.040	177.490	177.945	GBX -28,827	159.71 Loss of -2,955 on sale
2025-10-29	SELL	-54	180.150	191.410	190.284	GBX -10,275	159.60 Loss of -1,657 on sale
2025-10-28	BUY	52	187.930	193.470	192.916	GBX 10,032	159.46
2025-10-27	SELL	-54	195.280	198.000	197.728	GBX -10,677	159.28 Loss of -2,076 on sale
2025-10-22	SELL	-27	187.000	190.690	190.321	GBX -5,139	158.78 Loss of -852 on sale
2025-10-17	SELL	-108	178.520	178.770	178.745	GBX -19,304	158.40 Loss of -2,198 on sale
2025-10-16	BUY	135	174.950	177.750	177.470	GBX 23,958	158.31
2025-10-15	BUY	189	170.720	173.020	172.790	GBX 32,657	158.24
2025-10-14	BUY	27	170.130	172.410	172.182	GBX 4,649	158.18
2025-10-03	BUY	54	177.330	181.450	181.038	GBX 9,776	158.08
2025-10-02	BUY	27	175.360	178.190	177.907	GBX 4,803	157.99
2025-10-01	BUY	158	170.480	170.660	170.642	GBX 26,961	157.92
2025-09-18	BUY	27	156.990	157.630	157.566	GBX 4,254	158.16
2025-09-11	BUY	27	159.740	159.780	159.776	GBX 4,314	158.22
2025-09-10	BUY	27	153.270	157.970	157.500	GBX 4,253	158.25
2025-08-20	BUY	54	159.580	159.620	159.616	GBX 8,619	158.27
2025-08-19	BUY	27	158.480	160.000	159.848	GBX 4,316	158.26
2025-08-18	BUY	135	156.980	158.190	158.069	GBX 21,339	158.27
2025-08-15	BUY	402	156.680	158.160	158.012	GBX 63,521	158.28
2025-08-14	BUY	162	155.800	155.930	155.917	GBX 25,259	158.30
2025-08-13	BUY	108	155.000	155.430	155.387	GBX 16,782	158.32
2025-07-30	BUY	27	176.190	180.020	179.637	GBX 4,850	158.24
2025-07-17	SELL	-27	156.700	156.950	156.925	GBX -4,237	157.74 Profit of 22 on sale
2025-07-15	SELL	-108	154.420	159.490	158.983	GBX -17,170	157.77 Loss of -131 on sale
2025-07-14	SELL	-270	158.040	160.410	160.173	GBX -43,247	157.77 Loss of -648 on sale
2025-07-09	SELL	-27	158.970	163.590	163.128	GBX -4,404	157.72 Loss of -146 on sale
2025-07-07	SELL	-54	153.900	156.720	156.438	GBX -8,448	157.74 Profit of 70 on sale
2025-07-02	BUY	27	157.490	158.380	158.291	GBX 4,274	157.75
2025-06-24	SELL	-459	148.400	149.680	149.552	GBX -68,644	158.01 Profit of 3,881 on sale
2025-06-23	BUY	27	147.380	148.320	148.226	GBX 4,002	158.08
2025-06-20	SELL	-1,403	147.450	147.740	147.711	GBX -207,239	158.16 Profit of 14,659 on sale
2025-06-18	SELL	-28	145.290	147.100	146.919	GBX -4,114	158.35 Profit of 320 on sale
2025-06-17	BUY	336	145.050	150.540	149.991	GBX 50,397	158.45
2025-06-13	SELL	-56	149.450	152.640	152.321	GBX -8,530	158.57 Profit of 350 on sale
2025-06-11	SELL	-28	151.110	154.430	154.098	GBX -4,315	158.67 Profit of 128 on sale
2025-06-10	SELL	-56	151.000	152.430	152.287	GBX -8,528	158.73 Profit of 361 on sale
2025-06-09	SELL	-84	147.460	149.030	148.873	GBX -12,505	158.82 Profit of 836 on sale
2025-05-21	SELL	-28	134.980	141.710	141.037	GBX -3,949	161.13 Profit of 562 on sale
2025-05-20	SELL	-56	143.530	143.820	143.791	GBX -8,052	161.28 Profit of 979 on sale
2025-05-15	SELL	-84	138.890	139.380	139.331	GBX -11,704	161.83 Profit of 1,890 on sale
2025-05-14	SELL	-84	138.950	146.430	145.682	GBX -12,237	162.04 Profit of 1,374 on sale
2025-05-13	BUY	28	144.020	145.640	145.478	GBX 4,073	162.20
2025-05-09	SELL	-28	138.790	143.460	142.993	GBX -4,004	162.59 Profit of 549 on sale
2025-05-08	BUY	56	141.360	143.860	143.610	GBX 8,042	162.78
2025-05-01	BUY	56	116.890	120.140	119.815	GBX 6,710	164.79
2025-04-24	SELL	-28	115.760	115.940	115.922	GBX -3,246	167.27 Profit of 1,438 on sale
2025-04-23	BUY	84	109.000	116.060	115.354	GBX 9,690	167.87
2025-04-15	SELL	-28	105.920	107.580	107.414	GBX -3,008	171.99 Profit of 1,808 on sale
2025-04-11	SELL	-56	99.750	101.360	101.199	GBX -5,667	173.54 Profit of 4,051 on sale
2025-04-08	SELL	-28	123.610	137.960	136.525	GBX -3,823	175.38 Profit of 1,088 on sale
2025-04-07	SELL	-28	134.070	139.160	138.651	GBX -3,882	175.86 Profit of 1,042 on sale
2025-04-04	SELL	-56	136.900	140.150	139.825	GBX -7,830	176.33 Profit of 2,044 on sale
2025-04-02	BUY	28	149.280	150.160	150.072	GBX 4,202	176.65
2025-04-01	BUY	252	145.990	151.370	150.832	GBX 38,010	177.03
2025-03-31	SELL	-168	150.520	153.820	153.490	GBX -25,786	177.35 Profit of 4,009 on sale
2025-03-28	BUY	28	155.550	158.710	158.394	GBX 4,435	177.63
2025-03-26	SELL	-19	158.250	162.320	161.913	GBX -3,076	178.12 Profit of 308 on sale
2025-03-21	BUY	196	167.280	167.940	167.874	GBX 32,903	178.64
2025-03-20	BUY	112	165.350	171.710	171.074	GBX 19,160	178.82
2025-03-17	SELL	-28	175.010	175.600	175.541	GBX -4,915	178.97 Profit of 96 on sale
2025-03-12	BUY	1,035	170.590	171.190	171.130	GBX 177,120	179.39
2025-03-07	BUY	27	175.920	177.240	177.108	GBX 4,782	179.70
2025-02-28	SELL	-81	165.310	165.820	165.769	GBX -13,427	180.66 Profit of 1,206 on sale
2025-02-25	BUY	270	167.100	172.430	171.897	GBX 46,412	181.38
2025-02-20	BUY	189	162.250	168.020	167.443	GBX 31,647	182.26
2025-02-19	BUY	81	165.000	166.440	166.296	GBX 13,470	182.58
2025-02-18	BUY	54	154.390	155.690	155.560	GBX 8,400	183.11
2025-02-13	BUY	135	153.170	155.290	155.078	GBX 20,936	184.96
2025-02-04	BUY	108	163.120	169.670	169.015	GBX 18,254	188.84
2025-01-31	BUY	27	164.760	167.090	166.857	GBX 4,505	190.09
2025-01-29	BUY	27	161.640	163.000	162.864	GBX 4,397	191.44
2025-01-27	BUY	54	165.840	168.550	168.279	GBX 9,087	192.89
2025-01-24	BUY	27	164.970	168.150	167.832	GBX 4,531	193.66
2025-01-02	SELL	-972	182.640	187.320	186.852	GBX -181,620	194.78 Profit of 7,702 on sale
2024-12-10	SELL	-27	197.050	202.720	202.153	GBX -5,458	194.71 Loss of -201 on sale
2024-12-09	SELL	-702	201.750	202.570	202.488	GBX -142,147	194.49 Loss of -5,617 on sale
2024-12-03	SELL	-324	199.300	201.120	200.938	GBX -65,104	194.34 Loss of -2,137 on sale
2024-12-02	SELL	-135	201.250	203.010	202.834	GBX -27,383	194.09 Loss of -1,181 on sale
2024-11-29	SELL	-27	199.060	201.290	201.067	GBX -5,429	193.89 Loss of -194 on sale
2024-11-22	SELL	-270	195.770	198.180	197.939	GBX -53,444	192.73 Loss of -1,407 on sale
2024-11-21	SELL	-135	194.190	194.880	194.811	GBX -26,299	192.65 Loss of -291 on sale
2024-11-20	BUY	216	187.900	188.320	188.278	GBX 40,668	192.90
2024-11-18	SELL	-324	187.500	187.930	187.887	GBX -60,875	193.62 Profit of 1,858 on sale
2024-11-11	BUY	243	220.690	222.100	221.959	GBX 53,936	190.33
2024-11-08	SELL	-864	215.390	216.150	216.074	GBX -186,688	188.54 Loss of -23,789 on sale
2024-11-07	SELL	-54	210.290	217.600	216.869	GBX -11,711	186.87 Loss of -1,620 on sale
2024-11-01	SELL	-54	180.960	184.040	183.732	GBX -9,922	184.77 Profit of 56 on sale
2024-10-31	SELL	-108	178.580	181.230	180.965	GBX -19,544	185.55 Profit of 495 on sale
2024-10-30	BUY	27	181.390	186.370	185.872	GBX 5,019	186.14
2024-10-29	BUY	162	184.000	186.460	186.214	GBX 30,167	186.50
2024-10-28	SELL	-81	186.520	188.000	187.852	GBX -15,216	186.49 Loss of -110 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	98,139	1	131,075	74.9%
2025-09-18	62,997	2	121,436	51.9%
2025-09-17	92,129	0	727,005	12.7%
2025-09-16	115,396	12	317,673	36.3%
2025-09-15	66,356	1	151,093	43.9%
2025-09-12	77,557	0	176,817	43.9%
2025-09-11	87,999	1	204,237	43.1%
2025-09-10	122,656	0	398,564	30.8%
2025-09-09	125,402	0	471,642	26.6%
2025-09-08	178,342	0	414,729	43.0%
2025-09-05	76,264	0	192,668	39.6%
2025-09-04	94,792	0	179,533	52.8%
2025-09-03	139,646	0	216,265	64.6%
2025-09-02	112,819	30	183,910	61.3%
2025-08-29	105,965	1,040	180,206	58.8%
2025-08-28	183,971	4	248,978	73.9%
2025-08-27	71,891	0	134,034	53.6%
2025-08-26	109,853	19	166,152	66.1%
2025-08-25	147,166	23	300,781	48.9%
2025-08-22	251,126	0	414,085	60.6%
2025-08-21	102,152	0	149,376	68.4%
2025-08-20	152,721	0	215,946	70.7%
2025-08-19	118,831	0	172,887	68.7%
2025-08-18	93,028	0	164,641	56.5%
2025-08-15	96,500	1	180,165	53.6%
2025-08-14	147,952	0	251,456	58.8%
2025-08-13	820,206	0	1,075,153	76.3%
2025-08-12	299,322	0	438,699	68.2%
2025-08-11	192,917	0	365,058	52.8%
2025-08-08	92,089	66	222,128	41.5%
2025-08-07	326,647	522	550,230	59.4%
2025-08-06	532,434	7,827	888,873	59.9%
2025-08-05	283,148	6	539,938	52.4%
2025-08-04	124,111	54	248,834	49.9%
2025-08-01	162,441	300	281,622	57.7%
2025-07-31	125,648	0	228,706	54.9%
2025-07-30	115,487	0	188,121	61.4%
2025-07-29	181,159	0	275,843	65.7%
2025-07-28	198,896	49	321,941	61.8%
2025-07-25	162,642	111	293,831	55.4%
2025-07-24	385,658	456	820,472	47.0%
2025-07-23	150,650	0	346,020	43.5%
2025-07-22	205,736	26	821,853	25.0%
2025-07-21	132,794	101	445,920	29.8%
2025-07-18	93,150	207	186,542	49.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.